Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New combination HCV therapy launched in Germany

July 6, 2000

VX-497 plus interferon alfa enters phase II for the treatment of HCV

July 5, 2000

Commencement of phase II trials of WF-10 in hepatitis C announced

July 5, 2000

Patent issued to Meiji Seika covering benzoxazole derivatives and use for treating GI disorders

July 4, 2000

Potent HCV NS3 protease inhibitors designed at Italian laboratory

July 4, 2000

H. pylori antigenic protein for use in vaccines

July 3, 2000

May launch announced for UCB H2 receptor antagonist

June 30, 2000

NitroMed patents series of nitrosated or nitrosylated H2 antagonists

June 30, 2000

Korean laboratory presents new and improved proton pump inhibitors

June 29, 2000

Japanese patent covers new Meiji Milk peptide for H. pylori-related conditions

June 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026